Key statistics dashboard for Prenetics Global Limited (PRE). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Prenetics Global Limited is a consumer health sciences company that has pivoted to focus on a consumer health and longevity platform. The company's main brand is IM8, which offers science-backed nutritional supplements. It also operates CircleDNA, a consumer genetic testing brand that provides personalized health reports based on sequencing technology.
Stock Data
| Price | $24.19 |
| Market Cap | $411M |
| Enterprise Value | $338.2M |
| Beta | 0.27 |
| Exchange | NASDAQ |
| Country | HK |
Valuation Multiples
| P/E Ratio | -5.29 |
| Price / Book | 4.09 |
| P/S | 2.63 |
| EV/EBITDA | -5.41 |
| EV/Sales | 2.37 |
| EV/FCF | -9.91 |
| P/FCF | -10.96 |
| Earnings Yield | -16.78% |
| FCF Yield | -8.61% |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 62.61% |
| EBIT Margin | -46.77% |
| EBITDA Margin | -43.85% |
| Operating Margin | -35.20% |
| Net Margin | -47.43% |
| Return on Equity | -49.17% |
| Return on Assets | -44.00% |
| Return on Invested Capital | -42.66% |
| Return on Capital Employed | -42.85% |
Financial Health
| Current Ratio | 4.04 |
| Quick Ratio | 3.66 |
| Cash Ratio | 1.62 |
| Debt / Equity | 0.01 |
| Debt / Assets | 0.44% |
| Net Debt / EBITDA | 0.93 |
| Interest Coverage | -411.31 |
Per-Share Data
| Revenue per share | 8.26 |
| Book Value per share | 5.38 |
| Cash per share | 6.34 |
| FCF per share | -1.98 |
| Tangible Book Value per share | 5.38 |
| Dividend per share | 0.00 |
Related companies: ARMP · ATLN · CDXS · IMDX · MXCT · OSUR · PROF
Explore sector: Healthcare · Medical - Diagnostics & Research
More sections of PRE: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks